AbCellera Biologics IncEquity-NMS: ABCL
Equity-NMS: ABCL
$4.95
+0.08
(26 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$4.95
Open
$4.95
Today’s high
$4.96
Today’s low
$4.79
52W low
$3.87
52W high
$8.63
1Y
-41.28%
PE
-9.74
EPS (TTM)
-0.51
Shares O/S
292.78M
Market cap
1.45B
Insights
ABCL is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About AbCellera Biologics Inc

AbCellera Biologics Inc. is focused on the development of antibody-based drugs and is committed to improving discovery and development. It is engaged in antibody discovery and development engine is specifically designed to break the barriers of conventional discovery. It provides biotech and pharmaceutical companies with an advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development.

The Company uses the engine to both work with partners to build a large and diversified portfolio of royalty stakes in antibody drugs and to develop its own pipeline of antibody drugs. The Company partners with companies of all sizes, from biotechnology companies to pharmaceutical companies-propelling programs to the clinic, together. It generates a range of diverse antibodies with immunization strategies and single-cell screening. .


FAQs

Can I buy AbCellera Biologics Inc shares in India?
How to buy AbCellera Biologics Inc shares in India?
What is the share price of AbCellera Biologics Inc?
What is the Market Capitalization of AbCellera Biologics Inc?
What is the PE ratio of AbCellera Biologics Inc?
Is AbCellera Biologics Inc a good stock to buy?
In which sector / industry does AbCellera Biologics Inc operate?